Structural modifications around an antimalarial imidazopyridazine scaffold delivers analogues with improved solubility and hERG profiles.
No takes yet. Share an insight, caveat, or question.
Cheuka et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: